Advertisement

Index by Author

October 1987; 36 (10)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Anderson, J E

    • Primary hypoandrogenism in experimental diabetes in the Long-Evans rat. Diabetes October 1987 36:1104-1110; doi:10.2337/diabetes.36.10.1104

  2. Aronin, N

    • Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin. Diabetes October 1987 36:1139-1143; doi:10.2337/diabetes.36.10.1139

  3. Arquilla, E R

    • Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats. Diabetes October 1987 36:1144-1151; doi:10.2337/diabetes.36.10.1144

B

  1. Barbosa, J

    • Buffy coat transfusions in early type I diabetes. Diabetes October 1987 36:1089-1093; doi:10.2337/diabetes.36.10.1089

  2. Bell, P

    • Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial. Diabetes October 1987 36:1130-1138; doi:10.2337/diabetes.36.10.1130

  3. Berger, M

    • Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment. Diabetes October 1987 36:1178-1182; doi:10.2337/diabetes.36.10.1178

  4. Bergman, R N

    • Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes October 1987 36:1195-1202; doi:10.2337/diabetes.36.10.1195

  5. Binimelis, J

    • Buffy coat transfusions in early type I diabetes. Diabetes October 1987 36:1089-1093; doi:10.2337/diabetes.36.10.1089

  6. Brase, D A

    • Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes October 1987 36:1173-1177; doi:10.2337/diabetes.36.10.1173

  7. Brechtel, G

    • Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM. Diabetes October 1987 36:1187-1194; doi:10.2337/diabetes.36.10.1187

  8. Bright, G M

    • Quantitative assay for human cytoplasmic islet cell antibodies. Diabetes October 1987 36:1183-1186; doi:10.2337/diabetes.36.10.1183

C

  1. Calles-Escandon, J

    • Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes October 1987 36:1167-1172; doi:10.2337/diabetes.36.10.1167

  2. Cavanaugh, J

    • Buffy coat transfusions in early type I diabetes. Diabetes October 1987 36:1089-1093; doi:10.2337/diabetes.36.10.1089

  3. Chopek, M

    • Buffy coat transfusions in early type I diabetes. Diabetes October 1987 36:1089-1093; doi:10.2337/diabetes.36.10.1089

  4. Clements, R S, Jr

    • Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin. Diabetes October 1987 36:1139-1143; doi:10.2337/diabetes.36.10.1139

  5. Comens, P G

    • Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes October 1987 36:1124-1129; doi:10.2337/diabetes.36.10.1124

D

  1. Dewey, W L

    • Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes October 1987 36:1173-1177; doi:10.2337/diabetes.36.10.1173

  2. Dyrberg, T

    • Spontaneously diabetic BB rats have age-dependent islet beta-cell-specific surface antibodies at clinical onset. Diabetes October 1987 36:1111-1115; doi:10.2337/diabetes.36.10.1111

F

  1. Firth, R

    • Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial. Diabetes October 1987 36:1130-1138; doi:10.2337/diabetes.36.10.1130

G

  1. Gavin, J R, 3rd

    • Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes October 1987 36:1124-1129; doi:10.2337/diabetes.36.10.1124

  2. Gilbert, W R

    • Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes October 1987 36:1124-1129; doi:10.2337/diabetes.36.10.1124

  3. Gingerich, R L

    • Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes October 1987 36:1124-1129; doi:10.2337/diabetes.36.10.1124

  4. Glaser, E W

    • Nutrition and somatomedin. XVII. Circulating somatomedin C during treatment of diabetic ketoacidosis. Diabetes October 1987 36:1152-1160; doi:10.2337/diabetes.36.10.1152

  5. Glauber, H

    • Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM. Diabetes October 1987 36:1187-1194; doi:10.2337/diabetes.36.10.1187

  6. Goldstein, S

    • Nutrition and somatomedin. XVII. Circulating somatomedin C during treatment of diabetic ketoacidosis. Diabetes October 1987 36:1152-1160; doi:10.2337/diabetes.36.10.1152

H

  1. Han, Y H

    • Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes October 1987 36:1173-1177; doi:10.2337/diabetes.36.10.1173

  2. Hsia, T

    • Adoptive transfer of insulitis and diabetes in neonates of diabetes-prone and -resistant rats. Tissue localization of injected blasts. Diabetes October 1987 36:1116-1123; doi:10.2337/diabetes.36.10.1116

J

  1. Jenquin, M

    • Subunit structure, autophosphorylation, and tyrosine-specific protein kinase activity of hepatic insulin receptors in fetal, neonatal, and adult rats. Diabetes October 1987 36:1161-1166; doi:10.2337/diabetes.36.10.1161

  2. Jones, D

    • Primary hypoandrogenism in experimental diabetes in the Long-Evans rat. Diabetes October 1987 36:1104-1110; doi:10.2337/diabetes.36.10.1104

K

  1. Kemmer, F W

    • Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment. Diabetes October 1987 36:1178-1182; doi:10.2337/diabetes.36.10.1178

L

  1. Leeman, S E

    • Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin. Diabetes October 1987 36:1139-1143; doi:10.2337/diabetes.36.10.1139

  2. Leiva, A

    • Buffy coat transfusions in early type I diabetes. Diabetes October 1987 36:1089-1093; doi:10.2337/diabetes.36.10.1089

  3. Lernmark, A

    • Spontaneously diabetic BB rats have age-dependent islet beta-cell-specific surface antibodies at clinical onset. Diabetes October 1987 36:1111-1115; doi:10.2337/diabetes.36.10.1111

  4. Logothetopoulos, J

    • Adoptive transfer of insulitis and diabetes in neonates of diabetes-prone and -resistant rats. Tissue localization of injected blasts. Diabetes October 1987 36:1116-1123; doi:10.2337/diabetes.36.10.1116

M

  1. MacGregor, D

    • Adoptive transfer of insulitis and diabetes in neonates of diabetes-prone and -resistant rats. Tissue localization of injected blasts. Diabetes October 1987 36:1116-1123; doi:10.2337/diabetes.36.10.1116

  2. Madsen, O D

    • Proinsulin-specific monoclonal antibodies. Immunocytochemical application as beta-cell markers and as probes for conversion. Diabetes October 1987 36:1203-1211

  3. Marsh, M

    • Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial. Diabetes October 1987 36:1130-1138; doi:10.2337/diabetes.36.10.1130

  4. McDougall, B

    • Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats. Diabetes October 1987 36:1144-1151; doi:10.2337/diabetes.36.10.1144

  5. Michaels, R L

    • Prolactin enhances cell-to-cell communication among beta-cells in pancreatic islets. Diabetes October 1987 36:1098-1103; doi:10.2337/diabetes.36.10.1098

  6. Mooradian, A D

    • Blood-brain barrier choline transport is reduced in diabetic rats. Diabetes October 1987 36:1094-1097; doi:10.2337/diabetes.36.10.1094

P

  1. Parsons, J A

    • Prolactin enhances cell-to-cell communication among beta-cells in pancreatic islets. Diabetes October 1987 36:1098-1103; doi:10.2337/diabetes.36.10.1098

  2. Penner, S B

    • Primary hypoandrogenism in experimental diabetes in the Long-Evans rat. Diabetes October 1987 36:1104-1110; doi:10.2337/diabetes.36.10.1104

  3. Phillips, L S

    • Nutrition and somatomedin. XVII. Circulating somatomedin C during treatment of diabetic ketoacidosis. Diabetes October 1987 36:1152-1160; doi:10.2337/diabetes.36.10.1152

  4. Pipeleers, D

    • Spontaneously diabetic BB rats have age-dependent islet beta-cell-specific surface antibodies at clinical onset. Diabetes October 1987 36:1111-1115; doi:10.2337/diabetes.36.10.1111

  5. Polonsky, K S

    • Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes October 1987 36:1195-1202; doi:10.2337/diabetes.36.10.1195

R

  1. Rizza, R A

    • Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial. Diabetes October 1987 36:1130-1138; doi:10.2337/diabetes.36.10.1130

  2. Robbins, D C

    • Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes October 1987 36:1167-1172; doi:10.2337/diabetes.36.10.1167

  3. Rossetti, L

    • Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding. Diabetes October 1987 36:1212-1215; doi:10.2337/diabetes.36.10.1212

S

  1. Sheridan, J D

    • Prolactin enhances cell-to-cell communication among beta-cells in pancreatic islets. Diabetes October 1987 36:1098-1103; doi:10.2337/diabetes.36.10.1098

  2. Shulman, G I

    • Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding. Diabetes October 1987 36:1212-1215; doi:10.2337/diabetes.36.10.1212

  3. Sinha, M K

    • Subunit structure, autophosphorylation, and tyrosine-specific protein kinase activity of hepatic insulin receptors in fetal, neonatal, and adult rats. Diabetes October 1987 36:1161-1166; doi:10.2337/diabetes.36.10.1161

  4. Sorenson, R L

    • Prolactin enhances cell-to-cell communication among beta-cells in pancreatic islets. Diabetes October 1987 36:1098-1103; doi:10.2337/diabetes.36.10.1098

  5. Stenger, D

    • Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats. Diabetes October 1987 36:1144-1151; doi:10.2337/diabetes.36.10.1144

T

  1. Tacken, M

    • Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment. Diabetes October 1987 36:1178-1182; doi:10.2337/diabetes.36.10.1178

  2. Thliveris, J A

    • Primary hypoandrogenism in experimental diabetes in the Long-Evans rat. Diabetes October 1987 36:1104-1110; doi:10.2337/diabetes.36.10.1104

U

  1. Ulich, T R

    • Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats. Diabetes October 1987 36:1144-1151; doi:10.2337/diabetes.36.10.1144

V

  1. Valiquette, N

    • Adoptive transfer of insulitis and diabetes in neonates of diabetes-prone and -resistant rats. Tissue localization of injected blasts. Diabetes October 1987 36:1116-1123; doi:10.2337/diabetes.36.10.1116

  2. Van de Winkel, M

    • Spontaneously diabetic BB rats have age-dependent islet beta-cell-specific surface antibodies at clinical onset. Diabetes October 1987 36:1111-1115; doi:10.2337/diabetes.36.10.1111

  3. Vølund, A

    • Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes October 1987 36:1195-1202; doi:10.2337/diabetes.36.10.1195

W

  1. Wallace, P

    • Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM. Diabetes October 1987 36:1187-1194; doi:10.2337/diabetes.36.10.1187

Z

  1. Zawalich, W S

    • Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding. Diabetes October 1987 36:1212-1215; doi:10.2337/diabetes.36.10.1212

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement